DK0804252T3 - Monoamin-, diamid-, thiol-holdige metalchelateringsmidler - Google Patents

Monoamin-, diamid-, thiol-holdige metalchelateringsmidler

Info

Publication number
DK0804252T3
DK0804252T3 DK95922159T DK95922159T DK0804252T3 DK 0804252 T3 DK0804252 T3 DK 0804252T3 DK 95922159 T DK95922159 T DK 95922159T DK 95922159 T DK95922159 T DK 95922159T DK 0804252 T3 DK0804252 T3 DK 0804252T3
Authority
DK
Denmark
Prior art keywords
diamide
monoamine
thiol
chelating agents
containing metal
Prior art date
Application number
DK95922159T
Other languages
English (en)
Inventor
William Mcbride
Richard T Dean
Original Assignee
Diatide Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22962421&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0804252(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Diatide Inc filed Critical Diatide Inc
Application granted granted Critical
Publication of DK0804252T3 publication Critical patent/DK0804252T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/082—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being a RGD-containing peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid Fuels And Fuel-Associated Substances (AREA)
  • Sealing Material Composition (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK95922159T 1994-06-03 1995-06-01 Monoamin-, diamid-, thiol-holdige metalchelateringsmidler DK0804252T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/253,973 US7238340B1 (en) 1991-11-27 1994-06-03 Monoamine, diamide, thiol-containing metal chelating agents
PCT/US1995/006914 WO1995033497A1 (en) 1994-06-03 1995-06-01 Monoamine, diamide, thiol-containing metal chelating agents

Publications (1)

Publication Number Publication Date
DK0804252T3 true DK0804252T3 (da) 2003-10-06

Family

ID=22962421

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95922159T DK0804252T3 (da) 1994-06-03 1995-06-01 Monoamin-, diamid-, thiol-holdige metalchelateringsmidler

Country Status (14)

Country Link
US (2) US7238340B1 (da)
EP (1) EP0804252B1 (da)
JP (1) JP3727342B2 (da)
KR (1) KR100235137B1 (da)
CN (1) CN1093424C (da)
AT (1) ATE246939T1 (da)
BR (1) BR9507917A (da)
CA (1) CA2191951C (da)
DE (1) DE69531502T2 (da)
DK (1) DK0804252T3 (da)
ES (1) ES2204954T3 (da)
PT (1) PT804252E (da)
WO (1) WO1995033497A1 (da)
ZA (1) ZA954548B (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700444A (en) * 1992-02-20 1997-12-23 Rhomed Incorporated Chemotactic peptide pharmaceutical applications
DE69230525T2 (de) * 1991-02-08 2000-06-21 Diatide, Inc. Technetium-99m markierte Polypeptide zur Bildformung
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
US7238340B1 (en) * 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
US5989519A (en) * 1992-03-13 1999-11-23 Diatide, Inc. Technetium-99m labeled peptides for imaging inflammation
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
EP0727225A3 (en) * 1995-02-14 1997-01-15 Sonus Pharma Inc Compositions and methods for directed ultrasonic imaging
ATE353019T1 (de) * 1995-12-01 2007-02-15 Molecular Insight Pharm Inc Stereoisomere von fettsäureanalogen zur diagnostischen bildgebung
JP2001504801A (ja) * 1996-06-10 2001-04-10 ジー．ディー．サール アンド カンパニー 血栓サイトに局在化可能な放射性医薬組成物
US6083480A (en) 1997-05-01 2000-07-04 Diatide, Inc. Calcitonin receptor binding reagents
DE69838490T2 (de) * 1997-12-24 2008-02-07 Bracco International B.V. Peptide chelatoren die nach der koordination mit einem metall zu einem vorherrschenden einzel-stereoisomeren führen
US6334996B1 (en) 1997-12-24 2002-01-01 Resolution Pharmaceuticals Inc. Chelators that predominantely form a single stereoisomeric species upon coordination to a metal center
US6358491B1 (en) * 1999-08-27 2002-03-19 Berlex Laboratories, Inc. Somatostatin analogs
US6579967B1 (en) 1999-12-14 2003-06-17 The Salk Institute For Biological Studies Receptor-selective somatostatin analogs
US6475210B1 (en) * 2000-02-11 2002-11-05 Medventure Technology Corp Light treatment of vulnerable atherosclerosis plaque
US7122172B1 (en) 2000-03-08 2006-10-17 Gerhart Graupner Methods and compositions for targeted drug delivery
US7906103B2 (en) 2000-03-08 2011-03-15 Gerhard Graupner Methods and compositions for targeted drug delivery
US7019109B2 (en) * 2001-03-16 2006-03-28 The Salk Institute For Bilogical Studies SSTR1-selective analogs
AU2002327180A1 (en) 2001-06-04 2003-01-21 The General Hospital Corporation Detection and therapy of vulnerable plaque with photodynamic compounds
DE60230046D1 (de) * 2001-08-10 2009-01-08 Novartis Ag Peptide, die atherosklerotische schädigungen binden
US7943577B2 (en) * 2001-11-20 2011-05-17 Albany Medical College Alpha-fetoprotein peptides and uses thereof
AU2002363944A1 (en) * 2001-11-20 2003-06-10 Clf Medical Technology Acceleration Program, Inc. Alpha-fetoprotein peptides and uses for imaging
US7199255B2 (en) 2001-12-18 2007-04-03 Univation Technologies, Llc Imino-amide catalysts for olefin polymerization
US6864205B2 (en) 2001-12-18 2005-03-08 Univation Technologies, Llc Heterocyclic-amide catalyst compositions for the polymerization of olefins
US7001863B2 (en) 2001-12-18 2006-02-21 Univation Technologies, Llc Monoamide based catalyst compositions for the polymerization of olefins
WO2003092742A1 (en) * 2002-05-06 2003-11-13 Endocyte, Inc. Vitamin-targeted imaging agents
AU2003259172A1 (en) * 2002-07-24 2004-02-09 The Salk Institute For Biological Studies Receptor (sstr4)- selective somatostatin analogs
US20080260650A1 (en) * 2004-10-28 2008-10-23 The General Hospital Corporation Methods of Detection and Therapy of Inflamed Tissues Using Immune Modulation
US20080193376A1 (en) * 2004-10-28 2008-08-14 The General Hospital Corporation Methods of Enhanced Detection and Therapy of Inflamed Tissues Using Immune Modulation
US7560227B2 (en) * 2005-02-28 2009-07-14 University Of Massachusetts Biomarkers of vulnerable atherosclerotic plaques and methods of use
EP1717247A1 (en) * 2005-04-28 2006-11-02 Schering AG Cyclic peptides binding to the somatostatin receptor
WO2006114324A1 (en) * 2005-04-28 2006-11-02 Schering Ag Compounds comprising cyclized somatostatin receptor binding peptides
US7874975B2 (en) * 2005-07-20 2011-01-25 Clear Vascular, Inc. Methods and compositions for treating luminal inflammatory disease
US9623129B2 (en) * 2005-09-26 2017-04-18 Snip Holdings, Inc. Methods and therapies for treating inflammatory conditions with exposed collagen
US8691761B2 (en) * 2006-10-16 2014-04-08 Jean E. F. Rivier Somatostatin receptor 2 antagonists
PL2383289T3 (pl) 2006-10-16 2015-03-31 Salk Inst Biological Studies Antagoniści somatostatyny selektywni względem receptora (SSTR2)
WO2008143958A1 (en) * 2007-05-18 2008-11-27 The Brigham And Women's Hospital, Inc. Use of somatostatin analogs in myocardial perfusion imaging
CA2727803C (en) 2008-05-13 2013-03-12 University Of Kansas Metal abstraction peptide (map) tag and associated methods
JP5604680B2 (ja) * 2009-04-28 2014-10-15 国立大学法人 千葉大学 放射性標識薬剤
WO2011107870A2 (en) * 2010-03-05 2011-09-09 Mahesh Kandula Compounds and compositions and their use in the treatment of diseases related to copper retention
WO2013181461A2 (en) 2012-06-01 2013-12-05 University Of Kansas Metal abstraction peptide with superoxide dismutase activity

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444690A (en) 1982-02-25 1984-04-24 University Patents, Inc. Technetium chelates
US4472509A (en) 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4668503A (en) 1982-07-26 1987-05-26 Trustees Of University Of Massachusetts Process for labeling amines with 99m Tc
US4575556A (en) 1982-11-08 1986-03-11 Medi-Physics, Inc. Bifunctional chelating agents
US4571430A (en) 1982-11-08 1986-02-18 Medi-Physics, Inc. Homocysteine and homocysteinamide derivatives
US4434151A (en) 1982-11-08 1984-02-28 Medi-Physics, Inc. Bifunctional chelating agents
US4673562A (en) 1983-08-19 1987-06-16 The Children's Medical Center Corporation Bisamide bisthiol compounds useful for making technetium radiodiagnostic renal agents
US4732864A (en) 1983-10-06 1988-03-22 E. I. Du Pont De Nemours And Company Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
JPS61501321A (ja) 1984-01-23 1986-07-03 インスティテュト・フォ−・エネジテクニク たんぱく様物質標識用テクネチウム９９ｍ組成物およびその使用方法
US4943523A (en) 1984-01-30 1990-07-24 Enzo Biochem, Inc. Detectable molecules, method of preparation and use
US4638051A (en) 1984-04-30 1987-01-20 The Johns Hopkins University Brain imaging radiopharmaceuticals
US4980147A (en) * 1984-06-25 1990-12-25 University Of Utah Research Foundation Radiolabeled technetium chelates for use in renal function determinations
EP0200211A1 (en) 1985-05-01 1986-11-05 The Research Foundation Of State University Of New York Diagnostic radiopharmaceutical compounds
GB8525974D0 (en) 1985-10-22 1985-11-27 Nyegaard & Co As Chemical substance
US4877868A (en) 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
US4861869A (en) 1986-05-29 1989-08-29 Mallinckrodt, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
DE3728599A1 (de) 1986-12-10 1988-06-23 Hoechst Ag Verfahren zur herstellung einer mit technetium-99m-markierten organspezifischen substanz
US5279811A (en) 1987-02-18 1994-01-18 The Du Pont Merck Pharmaceutical Company Ester-substituted diaminedithiols and radiolabeled complexes thereof
ATE106898T1 (de) 1987-03-26 1994-06-15 Neorx Corp Metall-radionuklid-markierte proteine und glykoproteine zur diagnose und therapie.
US4965392A (en) 1987-03-26 1990-10-23 Neorx Corporation Chelating compounds for metal-radionuclide labeled proteins
US5091514A (en) 1987-03-26 1992-02-25 Neorx Corporation Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy
JPH02504387A (ja) 1987-04-02 1990-12-13 セントカー・カーデイオバスキユラー・イメージング・パートナーズ・エルピー 金属イオンで抗体を標識付けする方法
DE3730057C1 (de) 1987-08-22 1989-02-09 Hans Wahlers Vorschubwalze fuer eine Vorrichtung zum Bearbeiten von Baumstaemmen
WO1989007456A1 (en) 1988-02-09 1989-08-24 Mallinckrodt, Inc. Method of preparing a metal-radionuclide-labelled protein
US5061641A (en) 1988-04-01 1991-10-29 Immunomedics, Inc. Method for radiolabeling proteins
US5218128A (en) 1988-06-15 1993-06-08 Centocor, Inc. Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
US5180816A (en) 1988-08-24 1993-01-19 Centocor One vial method for labeling protein/linker conjugates with technetium-99M
US4925650A (en) 1988-11-16 1990-05-15 Mallinckrodt, Inc. Technetium -99m complex for examining the renal function
WO1990006323A2 (en) 1988-11-29 1990-06-14 Centocor, Inc. Chimeric proteins incorporating a metal binding protein
MY106120A (en) 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
US4986979A (en) 1989-03-14 1991-01-22 Neorx Corporation Imaging tissue sites of inflammation
US5196515A (en) 1989-03-17 1993-03-23 The Johns Hopkins University Thiolactone bifunctional chelating agents for diagnostic and therapeutic products
US5095111A (en) 1989-03-17 1992-03-10 The John Hopkins University Thiolactone bifunctional chelating agents for diagnostic and therapeutic products
CA2018710A1 (en) 1989-06-13 1990-12-13 Shieh-Shung T. Chen L-683,590 microbial transformation product
US5248764A (en) 1989-06-16 1993-09-28 Merck Frosst Canada, Inc. Chelate derivatives of atrial natriuretic factor (ANF)
GB8914020D0 (en) 1989-06-19 1989-08-09 Antisoma Ltd Synthetic peptides for use in thrombus detection
DE69018226T2 (de) 1989-07-20 1995-09-21 Sandoz-Patent-Gmbh, 79539 Loerrach Markierte polypeptidderivate.
FR2650672A1 (fr) 1989-08-02 1991-02-08 Medgenix Group Sa Procede de marquage de proteines ou polypeptides au technetium-99m, conjugue obtenu, utilisation a titre d'agent d'imagerie, kit de reconstitution desdits conjugues
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
US5985240A (en) * 1989-08-09 1999-11-16 Rhomed Incorporated Peptide radiopharmaceutical applications
FR2651077B1 (fr) 1989-08-18 1994-06-10 Letourneur Gregoire Dispositif de traitement d'echo notamment acoustique dans une ligne telephonique
HUT59166A (en) * 1989-12-08 1992-04-28 Univ Tulane Process for producing octqpeptide somatostatine analogues with treonine at the 6 position and pharmaceutical compositions containing them
US5112953A (en) 1989-12-29 1992-05-12 Neorx Corporation Radiolabeled proteins for diagnostic or therapeutic use
US5175257A (en) 1989-12-29 1992-12-29 Neorx Corporation Radiolabeled proteins for diagnostic or therapeutic use
US5178025A (en) 1990-08-31 1993-01-12 Innovative Medical Engineering, Inc. Tiltable lift seat devices
JP2860157B2 (ja) 1990-10-31 1999-02-24 日本メジフィジックス株式会社 腎機能測定用の既放射能標識テクネチウムキレート注射剤の製造方法
US7238340B1 (en) * 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
WO1993023085A1 (en) * 1992-05-21 1993-11-25 Diatech, Inc. TECHNETIUM-99m LABELED PEPTIDES FOR THROMBUS IMAGING
US5409894A (en) * 1991-03-14 1995-04-25 Sandoz Ltd. Method of preventing balloon catheterization blood vessel damage
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
ATE197767T1 (de) 1992-01-03 2000-12-15 Rhomed Inc Pharmazeutische anwendungen auf der basis von peptid-metall-ionen
WO1993015770A1 (en) 1992-02-05 1993-08-19 Mallinckrodt Medical, Inc. Radiolabelled peptide compounds
DK0630265T3 (da) * 1992-03-13 2003-06-30 Diatide Inc Technetium-99m mærkede peptider til afbildning af inflammation
US5326856A (en) 1992-04-09 1994-07-05 Cytogen Corporation Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding
US5620675A (en) * 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
US5688485A (en) * 1992-12-31 1997-11-18 The Dupont Merck Pharmaceutical Company Radiolabelled complexes of ester-substituted diaminethiols
NZ250653A (en) * 1993-01-12 1995-12-21 Sandoz Ltd Somatostatin derivatives and pharmaceutical or diagnostic imaging compositions
FR2701952B1 (fr) * 1993-02-22 1995-03-31 Adir Nouveaux dérivés cyclopeptidiques de l'angiopeptine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
CA2363780C (en) * 1993-04-08 2003-01-07 Diatide, Inc. Radiolabeled compounds for thrombus imaging
US5464934A (en) * 1993-05-14 1995-11-07 Mallinckrodt Medical, Inc. Metal chelates as spacer compounds in biologically active peptides
ATE337338T1 (de) * 1993-06-23 2006-09-15 Diatide Inc Radioaktiv-markierte peptidderivate des somatostatins zur bildformenden und therapeutischen verwendung
CA2189420A1 (en) * 1994-05-02 1995-11-09 Richard T. Dean Technetium-99m labeled imaging agents
US5662885A (en) 1994-07-22 1997-09-02 Resolution Pharmaceuticals Inc. Peptide derived radionuclide chelators
US5556939A (en) * 1994-10-13 1996-09-17 Merck Frosst Canada, Inc. TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
MY147327A (en) * 1995-06-29 2012-11-30 Novartis Ag Somatostatin peptides
US5708135A (en) * 1995-09-29 1998-01-13 Biomeasure Incorporated Cyclic peptide analogs of somatostatin

Also Published As

Publication number Publication date
ATE246939T1 (de) 2003-08-15
US7238340B1 (en) 2007-07-03
KR970703172A (ko) 1997-07-03
EP0804252B1 (en) 2003-08-13
CA2191951A1 (en) 1995-12-14
CA2191951C (en) 2009-01-27
BR9507917A (pt) 1997-08-12
CN1158090A (zh) 1997-08-27
WO1995033497A1 (en) 1995-12-14
DE69531502D1 (de) 2003-09-18
KR100235137B1 (ko) 1999-12-15
EP0804252A2 (en) 1997-11-05
ZA954548B (en) 1996-03-15
JP3727342B2 (ja) 2005-12-14
JPH10501531A (ja) 1998-02-10
CN1093424C (zh) 2002-10-30
DE69531502T2 (de) 2004-06-24
US5976496A (en) 1999-11-02
ES2204954T3 (es) 2004-05-01
PT804252E (pt) 2003-12-31

Similar Documents

Publication Publication Date Title
DK0804252T3 (da) Monoamin-, diamid-, thiol-holdige metalchelateringsmidler
SE9902987D0 (sv) Novel compounds
ATE248837T1 (de) Chinuclidin-acrylamide
AP9701041A0 (en) Pyridylpyrrole compounds.
MY140488A (en) Substituted oxazolidinones and their use in the field of blood coagulation
IL100100A0 (en) Novel hydroxamic acid and n-hydroxyurea derivatives and their use
BG101118A (en) Therapeutical compounds
DE60205455D1 (de) Naphthyridinderivate
MX9708621A (es) AGONISTAS beta-ADRENERGICOS, COMPOSICIONES QUE LOS CONTIENEN Y USO DE LOS MISMOS.
PA8486401A1 (es) Antibioticos cetolidos carbamato y carbazato
BG100930A (bg) Фармацевтични състави и лекарствени средства за профилактика и лечение на ендотелиални нарушения
DK0765320T3 (da) Benzimidazolonderivater med central dopaminerg aktivitet
ATE211729T1 (de) Therapeutisch wirksame verbindungen
ATE233754T1 (de) Diphenyl-piperidin derivate
EA200100516A1 (ru) Производные 3,3-биарилпиперидина и 2,2-биарилморфолина
FI970469A0 (fi) Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
IL163608A (en) Sulfonanilides are conserved in their amino / amino acids and derivatives, their process, their pharmaceutical preparations, and their conjugated antibodies and their use in the preparation of drugs for the treatment of culture disorders
TWI262791B (en) 6-methoxy-2-naphthylacetic acid prodrugs
MX9708618A (es) AGONISTAS beta-ADRENERGICOS, COMPOSICIONES QUE LOS CONTIENEN Y USO DE LOS MISMOS.
GB9926301D0 (en) Novel compounds
MX9604072A (es) Derivados de oxazolidinona y composiciones farmaceuticas que los contienen.